ADORA3 and asthma: Finally, considering the mechanisms of action, it seems that selective A2BAR agonists, A1AR and/or possibly A3AR antagonists, methylxanthines that lack A2A and A2B antagonist activity, and P2X7R antagonists should be particularly useful for the treatment of asthma.